found that serum albumin at presentation was significantly lower in patients with AKI, those requiring kidney replacement therapy and those with venous thromboembolic events, but was not associated with increased mortality in the IRoc-GN cohort (10). The gene discussed is ALB; the disease is ganglioneuroma.